TNFSF10 and cancer: More recently, the TRAIL-inducing small molecule, ONC201, which is being tested in clinical trials, was shown to effectively inhibit cancer metastasis and promote intratumoral NK cell recruitment, including stimulation of an increase in activated TRAIL-secreting NK cells in the peripheral blood of patients [39].